Bexmarilimab and azacitidine showed continued tolerability and a high overall response rate in relapsed/refractory higher-risk myelodysplastic syndromes in a phase 2 study.

Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory ...

The following is a summary of “Impaired LTB4-induced neutrophil chemotactic directionality in myelodysplastic neoplasms patients,” published in the April 2025 issue of Hematology by Xie et al.

MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with ...

The IND supports the initiation of a Phase II clinical trial of MNV-201 in pediatric patients with Pearson Syndrome, a primary mitochondrial disease. Based on previous clinical experience from the ...

MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria ...

The myelodysplastic syndromes (MDS) are disorders of the haematopoietic stem cells in the bone marrow, that result in a decreased production of blood cells. MDS mainly affects patients aged 70 and ...

Panelists discuss how health care institutions are leveraging strategic referral networks and telemedicine technologies to bridge geographical barriers, connect rural patients with specialized ...

Myelodysplastic syndromes (MDS) is a group of blood cancers. Red and white blood cells and platelets start as immature blood stem cells. In MDS, your blood stem cells do not mature into full ...

Neutropenia: a condition in which the body has a low ... therapy — which is already approved in the U.S. — for adults with lower-risk myelodysplastic syndromes who have anemia requiring frequent red ...

Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect infection and how that fails to happen in people with lupus. Research ...

Neutropenia may result from chemotherapy (common in leukemia treatment), bone marrow disorders like aplastic anaemia or myelodysplastic syndromes, infections, or side effects of certain medications.